Robinson Cole LLP
High Contrast Mode

Katherine R. Skonberg represents publicly and privately held companies across various areas of corporate and transactional law, including mergers and acquisitions, commercial finance transactions, private equity, and general corporate matters. She is a member of our firm’s Business Transactions group. 

Mergers + Acquisitions

Katherine regularly represents clients in all aspects of corporate transactions, including buyers and sellers in mergers and acquisitions, divestitures, and other strategic transactions. She has experience across a wide array of industries, allowing her to better serve clients of all sizes.

Commercial + Corporate Financing

Katherine has experience representing borrowers, banks, funds and other lenders, providing a unique perspective on how to structure financing documents to best help her clients. Her experience includes acquisition financing, asset-based financing, and mortgage financing.

General Corporate Matters

Katherine has worked with a variety of clients on general corporate matters, including entity formation, corporate governance, commercial contracting, debt and equity financing, transactions involving real estate, and other general corporate concerns.

Prior to joining Robinson+Cole she served as a Senior Legal Technology Solutions consultant for a consulting firm in Washington, D.C. Her experience there included managing a $5billion cross-country acquisition project that involved the Federal Trade Commission and the Canadian Competition Bureau. Katherine also collaborated with U.S. and U.K. law firms in managing the review of an investigation into price fixing.

  • Fordham University School of Law (Juris Doctor)
  • University of Virginia (Bachelors)
    • B.A., Political Science
    • French Minor

  • State of Connecticut
  • District of Columbia

News


April 10, 2025

Mergers + Acquisitions Team Represents Tradebe Life Sciences in Florachem Acquisition

Robinson+Cole recently represented Tradebe Life Sciences, a global business group dedicated to sustainability, in connection with its recent acquisition of Florachem, a leading provider of naturally derived, high-value concentrated fractions, extracts, and natural ingredients. Mergers + Acquisitions lawyers Adam Anderson and Kiernan Ignacio led the deal team, which included co-chair Matthew Guanci and member Katherine Skonberg, along with cross-disciplinary support from Christine Bromberg, Virginia McGarrity, Jacqueline Pennino Scheib, Nicole Diodati, Emilee Mooney Scott, Chuck Martin, and Austin Provost. The acquisition will expand Tradebe’s life sciences business by enhancing its focus on creating a circular economy by purifying and manufacturing essential ingredients. The deal also marks Tradebe’s entrance into the U.S market. Read the press release, here.

January 6, 2025

Robinson+Cole Serves as Legal Counsel in one of the “Top 5 Home Health & Hospice Deals of 2024”

LevinPro HC
July 19, 2024

Robinson+Cole Represents Vast Medical Group in Investment by Sumitomo Corporation

April 10, 2025

Mergers + Acquisitions Team Represents Tradebe Life Sciences in Florachem Acquisition

Robinson+Cole recently represented Tradebe Life Sciences, a global business group dedicated to sustainability, in connection with its recent acquisition of Florachem, a leading provider of naturally derived, high-value concentrated fractions, extracts, and natural ingredients. Mergers + Acquisitions lawyers Adam Anderson and Kiernan Ignacio led the deal team, which included co-chair Matthew Guanci and member Katherine Skonberg, along with cross-disciplinary support from Christine Bromberg, Virginia McGarrity, Jacqueline Pennino Scheib, Nicole Diodati, Emilee Mooney Scott, Chuck Martin, and Austin Provost. The acquisition will expand Tradebe’s life sciences business by enhancing its focus on creating a circular economy by purifying and manufacturing essential ingredients. The deal also marks Tradebe’s entrance into the U.S market. Read the press release, here.

January 6, 2025

Robinson+Cole Serves as Legal Counsel in one of the “Top 5 Home Health & Hospice Deals of 2024”

LevinPro HC
July 19, 2024

Robinson+Cole Represents Vast Medical Group in Investment by Sumitomo Corporation

July 18, 2024

Robinson+Cole Represents Signature Healthcare at Home’s Acquisition by the Pennant Group Inc.

December 12, 2022

R+C Plays Key Advisory Role in Keywords Studios’ Acquisition of Helpshift, Inc.

Law360

July 18, 2024

Robinson+Cole Represents Signature Healthcare at Home’s Acquisition by the Pennant Group Inc.

December 12, 2022

R+C Plays Key Advisory Role in Keywords Studios’ Acquisition of Helpshift, Inc.

Law360